| Metric | Q3 2025 | Q2 2025 | Q3 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $769M | — | — | — | — |
| Op. Income | $84M | — | — | — | — |
| Gross Margin | 39.9% | — | — | — | — |
| Net Margin | 8.8% | — | — | — | — |
| EPS (Diluted) | $0.15 | — | — | — | — |
| Free Cash Flow | -$175M | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $769M |
| Cost of Revenue | $462M |
| GROSS PROFIT | $307M |
| R&D Expenses | $0 |
| Selling & Marketing | $15M |
| General & Administrative | $149M |
| SG&A Expenses | $164M |
| Other Expenses | $58M |
| Operating Expenses | $222M |
| Cost & Expenses | $685M |
| OPERATING INCOME | $84M |
| Interest Income | $449M |
| Interest Expense | $333M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $84M |
| Income Tax Expense | $12M |
| Net Income from Continuing Ops | $72M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $68M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $68M |
| D&A | $17M |
| EBIT | $84M |
| EBITDA | $101M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| REVENUE | $769M |
| Cost of Revenue | $462M |
| GROSS PROFIT | $307M |
| R&D Expenses | $0 |
| Selling & Marketing | $15M |
| General & Administrative | $149M |
| SG&A Expenses | $164M |
| Other Expenses | $58M |
| Operating Expenses | $222M |
| Cost & Expenses | $685M |
| OPERATING INCOME | $84M |
| Interest Income | $449M |
| Interest Expense | $333M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $84M |
| Income Tax Expense | $12M |
| Net Income from Continuing Ops | $72M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $68M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $68M |
| D&A | $17M |
| EBIT | $84M |
| EBITDA | $101M |
| EPS | $0 |
| EPS Diluted | $0 |
| Item | Amount |
|---|---|
| Net Income | $68M |
| Depreciation & Amortization | $17M |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $152M |
| Change in Working Capital | -$410M |
| OPERATING CASH FLOW | -$173M |
| Capital Expenditure | -$2M |
| Acquisitions (Net) | $0 |
| Purchases of Investments | $0 |
| Sales/Maturities of Investments | $0 |
| Other Investing Activities | -$626M |
| NET CASH FROM INVESTING | -$629M |
| Net Debt Issuance | -$147M |
| Common Stock Repurchased | -$7M |
| Common Dividends Paid | -$7M |
| Other Financing Activities | $1.1B |
| NET CASH FROM FINANCING | $968M |
| FREE CASH FLOW | -$175M |
| Net Change in Cash | $174M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.8B |
| Short-Term Investments | $4.7B |
| Net Receivables | $252M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $6.9B |
| PP&E (Net) | $74M |
| Goodwill | $158M |
| Intangible Assets | $246M |
| Long-Term Investments | $9.7B |
| Tax Assets | $343M |
| Other Non-Current Assets | $1.0B |
| TOTAL NON-CURRENT ASSETS | $11.6B |
| TOTAL ASSETS | $18.5B |
| Account Payables | $2.3B |
| Short-Term Debt | $701M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $10.3B |
| TOTAL CURRENT LIABILITIES | $13.2B |
| Long-Term Debt | $2.6B |
| Deferred Revenue NC | $7M |
| Deferred Tax Liabilities | $9M |
| Other Non-Current Liabilities | $631M |
| TOTAL NON-CURRENT LIABILITIES | $3.3B |
| TOTAL LIABILITIES | $16.5B |
| Common Stock | $2.6K |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $2.0B |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $2.0B |
| Minority Interest | $26M |
| TOTAL EQUITY | $2.0B |
| TOTAL LIABILITIES & EQUITY | $18.5B |
| Total Debt | $3.3B |
| Net Debt | $1.5B |
